Telo Genomics Corp has seen a significant price change this week, attracting attention from Canadian investors.
Telo Genomics Corp (TELO.V) has experienced notable price action recently, with its stock rising sharply over the past week despite a decline today. As of the latest trading session, TELO.V closed down 9.09%, but it has gained 42.86% over the past week, reflecting a volatile yet intriguing performance for this health care company.
Investor takeaway: Investors should remain aware of Telo Genomics' stock fluctuations and consider the implications of its technical indicators and market conditions.
Advertisement
Telo Genomics Corp
TELO.V
TELO.V
Telo Genomics Corp
WealthAwesomeMarket cap
$5.02M
52W high
$0.10
52W low
$0.03
1W change
+42.86%
Beta
0.11
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELO's historical volatility
30-Day Vol
180.7%
Annualized
90-Day Vol
142.9%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.04
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.05 | C$0.03 – C$0.09 |
| 60 trading days | C$0.04 | C$0.02 – C$0.11 |
| 90 trading days | C$0.04 | C$0.01 – C$0.12 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Telo Genomics Corp's Stock Climbs 42.86% Over the Past Week
Despite today's decline, the stock has rallied significantly in the last week, indicating heightened trading activity and interest among investors.
Bull case
The recent price surge suggests that investors are increasingly interested in Telo Genomics. This interest may be fueled by positive sentiment regarding the company's prospects in the health care sector.
Bear case
The significant drop in today's trading could signal profit-taking or concerns about the company's financial fundamentals, which may warrant caution.
Recent Price Action
Advertisement
Telo Genomics Corp's stock has experienced a rollercoaster week, with a remarkable 42.86% increase over the past seven days. However, today's trading session saw a decline of 9.09%, closing at C$0.05. This volatility highlights the stock's dynamic nature and the potential for both gains and losses in a short period.
Technical Picture
From a technical standpoint, Telo Genomics' stock is currently trading above its 50-day moving average of C$0.04, which is a positive sign, representing a 13.1% increase versus the current price. The 200-day moving average stands at C$0.05, showing a modest gain of 0.8% compared to the last close. The stock has a 52-week range of C$0.03 to C$0.10, indicating it is currently trading at 36% of its range. With a low beta of 0.11, the stock tends to be less volatile compared to the broader market, which may appeal to risk-averse investors.
Volume Analysis
The latest trading session saw a volume of 54,100 shares, which is significantly below the 20-day average volume of 124,450 shares. This volume represents only 0.43 times the average, suggesting lower trading activity during this period. Such a discrepancy could indicate reduced investor participation or a consolidation phase as the market digests recent price movements.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
